<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02049606</url>
  </required_header>
  <id_info>
    <org_study_id>LAYLA_P4_NB</org_study_id>
    <nct_id>NCT02049606</nct_id>
  </id_info>
  <brief_title>To Compare the Efficacy and Safety of LAYLA in Osteoarthritis Patients of the Knee</brief_title>
  <official_title>Double Blinded, Randomized, Active Drug Comparative, Multi-center, Phase Ⅳ Clinical Study to Compare the Efficacy and Safety of LAYLA in Osteoarthritis Patients of the Knee.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>PMG Pharm Co., Ltd</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>PMG Pharm Co., Ltd</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a randomized, double-blind study to compare the efficacy and safety of LAYLA tablet
      and CENATONE tablet in the treatment of osteoarthritis of the knee.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">February 24, 2014</start_date>
  <completion_date type="Actual">May 30, 2016</completion_date>
  <primary_completion_date type="Actual">May 11, 2015</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Changes from the baseline in 100mm Pain VAS</measure>
    <time_frame>Baseline through week8</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Changes rate from the baseline in 100mm Pain VAS</measure>
    <time_frame>8 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Changes from the baseline in WOMAC</measure>
    <time_frame>8 Weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Changes from the baseline in EQ-5D</measure>
    <time_frame>8 Weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Changes in the patient self-assessed overall symptom score</measure>
    <time_frame>8 Weeks</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">134</enrollment>
  <condition>Osteoarthritis of the Knee</condition>
  <arm_group>
    <arm_group_label>LAYLA</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Drug : LAYLA tablet/bid</description>
  </arm_group>
  <arm_group>
    <arm_group_label>CENATONE</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Drug : CENATONE tablet/qd</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>LAYLA tablet</intervention_name>
    <description>1 Tablet twice a day</description>
    <arm_group_label>LAYLA</arm_group_label>
    <other_name>LAYLA 405.4mg</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>CENATONE tablet</intervention_name>
    <description>2 Tablets once a day</description>
    <arm_group_label>CENATONE</arm_group_label>
    <other_name>Nabumetone 500mg</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients ≥40 and ≤80 years of age

          -  Radiographic evidence of grade 1,2 or 3 osteoarthritis based on the Kellgren &amp;
             Lawrence radiographic entry criteria

          -  Stable osteoarthritis during 3 months

          -  Score of 100mm Pain VAS ≤ 80mm at screening

          -  Score of 100mm Pain VAS ≥ 40mm at baseline

          -  Written consent form voluntarily

        Exclusion Criteria:

          -  Disease of spine or other Lower limb joints that could affect fo evaluate the efficacy

          -  History of surgery or arthroscopy of the study joint within 6 months

          -  Trauma of study joint within 12 months

          -  Medication of constantly(more than 1 week) corticosteroid by oral within 3 months

          -  Diagnosed with psychical disorder, and taking medication

          -  Medication of intra-articular injection within 3 months

          -  Uncontrollable Hypertension patients at screening test

          -  History of upper gastrointestinal ulceration within 6 months, History of upper
             gastrointestinal bleeding within 12 months

          -  History of lower gastrointestinal bleeding within 12 months

          -  History of coronary artery bypass, systemic lupus erythematosus or mixed connective
             tissue disease

          -  Serum creatinine, ALT, AST, total bilirubin over ULN X 2.0 at screening test

          -  History of hypersensitivity of LAYLA, CENATONE or NSAIDs

          -  Participation in another clinical trials within 4 weeks

          -  Medication of constantly (more than 1 week) narcotic analgesics within 3 months

          -  Not consent about using effectual contraception method during trial

          -  Pregnant or lactating woman

          -  History of malignant tumor within 5 years

          -  Investigator's judgment
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>40 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Seung Baik Kang, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>SMG-SNU Boramae Medical Center</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Jeong Ku Ha, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Inje University</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Han Jun Lee, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Chung-Ang University Hosptial, Chung-Ang University College of Medicine</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Yong In, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>The Catholic University of Korea</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Jong Min Kim, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Asan Medical Center</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Sahng Hoon Lee, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Seoul National University Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Asan Medical Center</name>
      <address>
        <city>Seoul</city>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Chung-Ang University Hospital</name>
      <address>
        <city>Seoul</city>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Inje University Seoul Paik Hospital</name>
      <address>
        <city>Seoul</city>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Seoul National University Hospital</name>
      <address>
        <city>Seoul</city>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>SMG-SNU Boramae Medical Center</name>
      <address>
        <city>Seoul</city>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>The Catholic University of Korea, Seoul ST. Mary's Hospital</name>
      <address>
        <city>Seoul</city>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <verification_date>September 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 28, 2014</study_first_submitted>
  <study_first_submitted_qc>January 29, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 30, 2014</study_first_posted>
  <last_update_submitted>September 18, 2017</last_update_submitted>
  <last_update_submitted_qc>September 18, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">September 20, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>LAYLA</keyword>
  <keyword>Non-inferiority</keyword>
  <keyword>100mm pain VAS</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Osteoarthritis</mesh_term>
    <mesh_term>Osteoarthritis, Knee</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

